Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter study.

Germing, U; Lauseker, M; Hildebrandt, B; Symeonidis, A; Cermak, J; Fenaux, P; Kelaidi, C; Pfeilstöcker, M; Nösslinger, T; Sekeres, M; Maciejewski, J; Haase, D; Schanz, J; Seymour, J; Kenealy, M; Weide, R; Lübbert, M; Platzbecker, U; Valent, P; Götze, K; Stauder, R; Blum, S; Kreuzer, KA; Schlenk, R; Ganser, A; Hofmann, WK; Aul, C; Krieger, O; Kündgen, A; Haas, R; Hasford, J; Giagounidis, A

doi:10.1038/leu.2011.391

2012

Back
Back to start of result list
Permanent link for displayed object

Document type:: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Article
Author(s):: Germing, U; Lauseker, M; Hildebrandt, B; Symeonidis, A; Cermak, J; Fenaux, P; Kelaidi, C; Pfeilstöcker, M; Nösslinger, T; Sekeres, M; Maciejewski, J; Haase, D; Schanz, J; Seymour, J; Kenealy, M; Weide, R; Lübbert, M; Platzbecker, U; Valent, P; Götze, K; Stauder, R; Blum, S; Kreuzer, KA; Schlenk, R; Ganser, A; Hofmann, WK; Aul, C; Krieger, O; Kündgen, A; Haas, R; Hasford, J; Giagounidis, A
Title:: Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter study.
Abstract:: Myelodysplastic syndromes (MDS) with del(5q) are considered to have a benign course of the disease. In order to address the issue of the propensity of those patients to progress to acute myeloid leukemia (AML), data on 381 untreated patients with MDS and del(5q) characterized by low or intermediate I International Prognostic Scoring System (IPSS) risk score were collected from nine centers and registries. Median survival of the entire group was 74 months. Transfusion-dependent patients had a median survival of 44 months vs 97 months for transfusion-independent patients (P<0.0001). Transfusion need at diagnosis was the most important patient characteristic for survival. Of the 381 patients, 48 (12.6%) progressed to AML. The cumulative progression rate calculated using the Kaplan-Meier method was 4.9% at 2 years and 17.6% at 5 years. Factors associated with the risk of AML transformation were high-risk World Health Organization adapted Prognostic Scoring System (WPSS) score, marrow blast count >5% and red-cell transfusion dependency at diagnosis. In conclusion, patients with MDS and del(5q) are facing a considerable risk of AML transformation. More detailed cytogenetic and molecular studies may help to identify the patients at risk of progression.
Journal title abbreviation:: Leukemia
Year:: 2012
Journal volume:: 26
Journal issue:: 6
Pages contribution:: 1286-92
Language:: eng
Fulltext / DOI:: doi:10.1038/leu.2011.391
Pubmed ID:: http://view.ncbi.nlm.nih.gov/pubmed/22289990
Print-ISSN:: 0887-6924
TUM Institution:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Occurrences:

mediaTUM Gesamtbestand Einrichtungen Hochschulpräsidium TUM Senior Excellence Faculty

mediaTUM Gesamtbestand Einrichtungen Schools TUM School of Medicine and Health Departments Clinical Medicine Klinik und Poliklinik für Innere Medizin III, Hämatologie und Onkologie (Prof. Bassermann)2012